Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors - Top-Institutions - MDSpire

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

  • By

  • Neel S. Bhatt

  • Fang Wang

  • Shizue Izumi

  • Yan Chen

  • Timothy J. D. Ohlsen

  • Gregory T. Armstrong

  • I-Chan Huang

  • Anne Kirchhoff

  • Elyse R. Park

  • Claire Snyder

  • K. Robin Yabroff

  • Yutaka Yasui

  • Paul C. Nathan

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Childhood Cancer Survivor Study
    Childhood Cancer Survivor Study

    Multiple Locations, N/A

    Key Differentiators

    • Pediatric Oncology

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Cancer Research

  • #3

    Institutional Review Boards of all collaborating centers
    Institutional Review Boards of all collaborating centers

    Multiple Locations, N/A

    Key Differentiators

    • Research Ethics

  • #4

    31 institutions in the US and Canada
    31 institutions in the US and Canada

    Multiple Locations, N/A

    Key Differentiators

    • Pediatric Oncology

  • #5

    St. Jude Children’s Research Hospital
    St. Jude Children’s Research Hospital

    Memphis, Tennessee

    Key Differentiators

    • Pediatric Oncology

Original Source(s)

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

  • by Neel S. Bhatt, Fang Wang, Shizue Izumi, Yan Chen, Timothy J. D. Ohlsen, Gregory T. Armstrong, I-Chan Huang, Anne Kirchhoff, Elyse R. Park, Claire Snyder, K. Robin Yabroff, Yutaka Yasui, Paul C. Nathan

  • May 29, 2026

Related Content

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026